TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Responsible reporting: Case against acute kidney failure 'cure'

The media has a responsibility to the public in reporting medical facts accurately and in a well-structured article that avoids potential misinterpretation.

Stephanie Kusumo and Winda Liviya Ng (The Jakarta Post)
Premium
Jakarta
Wed, November 9, 2022

Share This Article

Change Size

Responsible reporting: Case against acute kidney failure 'cure' Fomepizole is a competitive inhibitor that can treat the type of kidney failure that results only from poisoning by ethylene glycol and diethylene glycol, the two harmful substances identified in contaminated cough syrup. (Unsplash/Tanaphong Toochinda)

T

hose who have been following the news must know that Indonesia has been seeing an unusually high number of cases of acute kidney injury and associated fatality among children under 5, recording 324 cases and 195 deaths as of Nov. 6, 2022.

It was suspected that these cases of acute kidney injury stem from contaminated children’s cough syrup. The Health Ministry thus recently suspended all nationwide sales of cough syrup as the Food and Drug Monitoring Agency (BPOM) worked to complete its investigation into the incident.

A couple of weeks ago, we began seeing news articles on confirmation of the contaminated cough syrup, the potential use of fomepizole as an antidote for acute kidney injury, and how the government was working to source the rare antidote from overseas. No less than 246 vials of fomepizole have now been acquired, 216 of which were donated from Japan and Australia and the remainder purchased from Singapore.

All was good and well.

Just a few days ago, however, several of our nonmedical contacts started asking us the most bizarre questions, such as whether “fomepizole can really cure acute kidney failure” and if they should try to purchase it for their relatives, one way or another.

We were quite shocked, and asked them to share the article from which they acquired that information. It was an article published on Kompas.com, a reputable, major news outlet, that mentioned throughout how fomepizole could “cure acute kidney failure”. Only in the last paragraph did the article mention that “10-11 patients with acute kidney failure due to poisoning from contaminated cough syrup recovered after the administration of fomepizole”.

Viewpoint

Every Thursday

Whether you're looking to broaden your horizons or stay informed on the latest developments, "Viewpoint" is the perfect source for anyone seeking to engage with the issues that matter most.

By registering, you agree with The Jakarta Post's

Thank You

for signing up our newsletter!

Please check your email for your newsletter subscription.

View More Newsletter

This could potentially lead untrained readers to believe that fomepizole is a miracle drug that can cure any form of acute kidney failure, which is not true.

to Read Full Story

  • Unlimited access to our web and app content
  • e-Post daily digital newspaper
  • No advertisements, no interruptions
  • Privileged access to our events and programs
  • Subscription to our newsletters
or

Purchase access to this article for

We accept

TJP - Visa
TJP - Mastercard
TJP - GoPay

Redirecting you to payment page

Pay per article

Responsible reporting: Case against acute kidney failure 'cure'

Rp 29,000 / article

1
Create your free account
By proceeding, you consent to the revised Terms of Use, and Privacy Policy.
Already have an account?

2
  • Palmerat Barat No. 142-143
  • Central Jakarta
  • DKI Jakarta
  • Indonesia
  • 10270
  • +6283816779933
2
Total Rp 29,000

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.